Page last updated: 2024-10-30

2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and B-Cell Chronic Lymphocytic Leukemia

2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one has been researched along with B-Cell Chronic Lymphocytic Leukemia in 11 studies

2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one: specific inhibitor of phosphatidylinositol 3-kinase; structure in first source

Research Excerpts

ExcerptRelevanceReference
"Although B chronic lymphocytic leukemia (B-CLL) cells express the alpha chain of the interleukin-2 (IL-2) receptor CD25, little is known about the effect of IL-2 on apoptosis in B-CLL cells."1.36Antiapoptotic effect of interleukin-2 (IL-2) in B-CLL cells with low and high affinity IL-2 receptors. ( Bogner, C; Decker, T; Oelsner, M; Peschel, C; Ringshausen, I, 2010)
"The development and the propagation of chronic lymphocytic leukemia (CLL) has been linked to signaling via the B-cell receptor (BCR)."1.35PKCbeta is essential for the development of chronic lymphocytic leukemia in the TCL1 transgenic mouse model: validation of PKCbeta as a therapeutic target in chronic lymphocytic leukemia. ( Denk, U; Egle, A; Greil, R; Heyder, C; Hofbauer, S; Holler, C; Piñón, JD, 2009)
"Apoptosis of B cell chronic lymphocytic leukemia (B-CLL) cells is regulated by the PI-3K-Akt pathway."1.33Regulation of Akt/PKB by phosphatidylinositol 3-kinase-dependent and -independent pathways in B-cell chronic lymphocytic leukemia cells: role of protein kinase C{beta}. ( Barragán, M; Campàs, C; Castaño, E; Coll-Mulet, L; Cosialls, AM; de Frias, M; Domingo, A; Gil, J; Iglesias-Serret, D; Pons, G; Santidrián, AF, 2006)

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's9 (81.82)29.6817
2010's2 (18.18)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mango, RL1
Wu, QP1
West, M1
McCook, EC1
Serody, JS1
van Deventer, HW1
Holler, C1
Piñón, JD1
Denk, U1
Heyder, C1
Hofbauer, S1
Greil, R1
Egle, A1
Niedermeier, M1
Hennessy, BT1
Knight, ZA1
Henneberg, M1
Hu, J1
Kurtova, AV1
Wierda, WG1
Keating, MJ1
Shokat, KM1
Burger, JA1
Decker, T1
Bogner, C1
Oelsner, M1
Peschel, C1
Ringshausen, I1
Jones, DT2
Ganeshaguru, K2
Anderson, RJ1
Jackson, TR1
Bruckdorfer, KR1
Low, SY1
Palmqvist, L1
Prentice, HG2
Hoffbrand, AV2
Mehta, AB2
Wickremasinghe, RG2
Mone, AP1
Huang, P1
Pelicano, H1
Cheney, CM1
Green, JM1
Tso, JY1
Johnson, AJ1
Jefferson, S1
Lin, TS1
Byrd, JC1
Plate, JM1
Breslin, EM1
White, PC1
Shore, AM1
Clement, M1
Brennan, P1
Kawauchi, K1
Ihjima, K1
Yamada, O1
Barragán, M1
de Frias, M1
Iglesias-Serret, D1
Campàs, C1
Castaño, E1
Santidrián, AF1
Coll-Mulet, L1
Cosialls, AM1
Domingo, A1
Pons, G1
Gil, J1
Lindsay, C1
Spanswick, VJ1
Hartley, JA1
Wadhwa, M1
Thorpe, R1

Other Studies

11 other studies available for 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and B-Cell Chronic Lymphocytic Leukemia

ArticleYear
C-C chemokine receptor 5 on pulmonary mesenchymal cells promotes experimental metastasis via the induction of erythroid differentiation regulator 1.
    Molecular cancer research : MCR, 2014, Volume: 12, Issue:2

    Topics: Animals; CCR5 Receptor Antagonists; Cell Line, Tumor; Chromones; Coculture Techniques; Female; Gene

2014
PKCbeta is essential for the development of chronic lymphocytic leukemia in the TCL1 transgenic mouse model: validation of PKCbeta as a therapeutic target in chronic lymphocytic leukemia.
    Blood, 2009, Mar-19, Volume: 113, Issue:12

    Topics: Aged; Aged, 80 and over; Alleles; Animals; B-Lymphocytes; CD5 Antigens; Cell Line, Tumor; Chromones;

2009
Isoform-selective phosphoinositide 3'-kinase inhibitors inhibit CXCR4 signaling and overcome stromal cell-mediated drug resistance in chronic lymphocytic leukemia: a novel therapeutic approach.
    Blood, 2009, May-28, Volume: 113, Issue:22

    Topics: 1-Phosphatidylinositol 4-Kinase; Actin Cytoskeleton; Antineoplastic Combined Chemotherapy Protocols;

2009
Antiapoptotic effect of interleukin-2 (IL-2) in B-CLL cells with low and high affinity IL-2 receptors.
    Annals of hematology, 2010, Volume: 89, Issue:11

    Topics: Apoptosis; Chromones; Humans; Interleukin-2; Interleukin-2 Receptor alpha Subunit; Leukemia, Lymphoc

2010
Albumin activates the AKT signaling pathway and protects B-chronic lymphocytic leukemia cells from chlorambucil- and radiation-induced apoptosis.
    Blood, 2003, Apr-15, Volume: 101, Issue:8

    Topics: Apoptosis; Chlorambucil; Chromones; Endocytosis; Enzyme Inhibitors; Gamma Rays; Humans; Leukemia, Ly

2003
Hu1D10 induces apoptosis concurrent with activation of the AKT survival pathway in human chronic lymphocytic leukemia cells.
    Blood, 2004, Mar-01, Volume: 103, Issue:5

    Topics: Acetylcysteine; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Ap

2004
PI3-kinase regulates survival of chronic lymphocytic leukemia B-cells by preventing caspase 8 activation.
    Leukemia & lymphoma, 2004, Volume: 45, Issue:8

    Topics: Apoptosis; Calpain; Caspase 8; Caspase Inhibitors; Caspases; Cell Cycle; Cell Survival; Chromones; C

2004
LY294002 and rapamycin co-operate to inhibit T-cell proliferation.
    British journal of pharmacology, 2005, Volume: 144, Issue:6

    Topics: Cell Line, Tumor; Cell Proliferation; Cell Survival; Chromones; Drug Interactions; Enzyme Inhibitors

2005
IL-2 increases human telomerase reverse transcriptase activity transcriptionally and posttranslationally through phosphatidylinositol 3'-kinase/Akt, heat shock protein 90, and mammalian target of rapamycin in transformed NK cells.
    Journal of immunology (Baltimore, Md. : 1950), 2005, May-01, Volume: 174, Issue:9

    Topics: Cell Line, Transformed; Chromones; DNA-Binding Proteins; Enzyme Inhibitors; Extracellular Signal-Reg

2005
Regulation of Akt/PKB by phosphatidylinositol 3-kinase-dependent and -independent pathways in B-cell chronic lymphocytic leukemia cells: role of protein kinase C{beta}.
    Journal of leukocyte biology, 2006, Volume: 80, Issue:6

    Topics: Apoptosis; Carcinogens; Chromones; Enzyme Inhibitors; Humans; Leukemia, Lymphocytic, Chronic, B-Cell

2006
Autologous plasma activates Akt/protein kinase B and enhances basal survival and resistance to DNA damage-induced apoptosis in B-chronic lymphocytic leukaemia cells.
    British journal of haematology, 2001, Volume: 114, Issue:3

    Topics: Antineoplastic Agents, Alkylating; Apoptosis; Blotting, Western; Chlorambucil; Chromones; Drug Resis

2001